CY
Cynata Therapeutics Limited
CYYNF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $2.92M
P/E Ratio -
Div. Yield -
ROE 133.81%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
1/9Valuation
94 /100
Cheap P/B 0.49x
P/S 1.55x
P/FFO N/A
Growth
0 /100
Declining Book val. growth 37.03%
Rev. growth 37.63%
FCF growth N/A
Profitability
20 /100
Weak Net margin 498.14%
Op. margin 430.95%
FCF margin 465.24%
Quality
3 /100
Poor ROE 133.81%
ROA 130.46%
Asset turnover 0.26x
Debt
100 /100
Low Current ratio 4.40x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
19 /100
Unstable Rev. volatility 59.34%
EPS volatility 110.20%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CYYNF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Kilian Kelly
Employees
2
Headquarters
Cremorne
Upcoming events
25 FEB
Earnings
Upcoming earnings report